Time: 13:10

AusBiotech

Calling Australian exporters for international business survey

Australian exporting companies are invited to participate in Australia’s International Business Survey (AIBS), which seeks to understand characteristics of Australian exporters and how to assist their international activities. Recognising trade and investment as a fundamental aspect of a strong economy, AIBS provides exporting companies the opportunity to voice their opinion and provide valuable input for … Continue reading Calling Australian exporters for international business survey

Medtech features in April journal

The Australian medtech sector takes centre stage in the April edition of Australasian Biotechnology, AusBiotech’s official journal, in anticipation of the upcoming AusMedtech 2017 and International Conference on Mechanics in Medicine and Biology (ICMMB) 2017 conference. This edition provides in-depth commentary on clinical trials, digital health, investment trends, regulatory updates, research breakthroughs and other topics … Continue reading Medtech features in April journal

Peak bodies unite against threat to commercialisation of Australian medical research

AusBiotech has joined fellow organisations – Research Australia, Medicines Australia, Medical Technologies Association of Australia and BioMelbourne Network – in a joint statement urging the Federal Government not to devastate Australia’s most innovative industry by gutting the Research & Development (R&D) Tax Incentive. The statement says that the commercialisation of Australian medical research is under … Continue reading Peak bodies unite against threat to commercialisation of Australian medical research

Asian Investor series confirms strong investor interest

The AusBiotech-led Asian Investment Series has confirmed investor interest in the Australian life science industry is strong and intensifying. Almost 400 delegates gathered to hear 21 Australian biotechnology and medical technology companies present their investment proposition as part of the Series, which was held in Singapore, Hong Kong and Shanghai during March. AusBiotech CEO, Glenn … Continue reading Asian Investor series confirms strong investor interest

Mimotopes fights to survive after administrative error

Leading provider of peptides for cancer research, Mimotopes, is facing eviction from its $10 million purpose-built facility and ultimately ceasing operations altogether, after notice to exercise its lease renewal was late due to a clerical oversight. As a vital component of the Australian and global medical research sector, the forced closure of Mimotopes, which was … Continue reading Mimotopes fights to survive after administrative error

AusBiotech says R&D Tax Incentive critical to 2030 Innovation Strategy

Preserving the R&D Tax Incentive will be top priority as AusBiotech coordinates comment for Innovation and Science Australia’s (ISA) consultation to develop a 2030 Strategic Plan for Australian innovation, science and its research system. AusBiotech believes the destruction that will be caused if the proposed $2 million cap proceeds will seriously and immediately impact the … Continue reading AusBiotech says R&D Tax Incentive critical to 2030 Innovation Strategy

AusBiotech endorses changes for accessing unapproved therapeutic goods

AusBiotech has made a submission endorsing proposed changes to improved access options for unapproved therapeutic goods, which are intended to reduce time and administrative burden and greatly improve efficiencies for applicants. The proposed changes to the Authorised Prescriber (AP) Scheme and the Special Access Scheme (SAS) have arisen from implementation of a number of Review … Continue reading AusBiotech endorses changes for accessing unapproved therapeutic goods

Competition for technology SMEs opens for 2017

Australian technology accelerator program, Australian Technologies Competition, is now open for 2017 to Australian technology SMEs with global potential. The Competition provides valuable profile and mentoring opportunities for successful applicants and has provided more than $250 million dollars in investment for Australian SMEs since it was established seven years ago. The top 30 applicants will … Continue reading Competition for technology SMEs opens for 2017

Women’s luncheon proves inspirational

The second AusBiotech NSW Women in Life Sciences Luncheon was warmly received as guest speakers, Melissa McGregor, Dr Elizabeth Eastland and Jacqueline Savage, united and inspired the 270 women who attended. Hosted by AusBiotech Deputy CEO, Lorraine Chiroiu, the luncheon, introduced the theme ‘women with courage’: “The courage to lead; the courage to face what … Continue reading Women’s luncheon proves inspirational